Bulk Dynamic Spray Freeze-Drying Part 2: Model-Based Parametric Study for Spray-Freezing Process Characterization.


Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
06 2019
Historique:
received: 02 10 2018
revised: 29 12 2018
accepted: 11 01 2019
pubmed: 27 1 2019
medline: 18 7 2020
entrez: 26 1 2019
Statut: ppublish

Résumé

Spray freeze-drying is an evolving technology that combines the benefits of spray-drying and conventional lyophilization techniques to produce drug substance and drug product as free-flowing powders. The high surface-to-volume ratio associated to the submillimeter spray-frozen particles contributes to shorter drying and reconstitution times. The formation of frozen particles is the most critical part of this dehydration technique because it defines the properties of final product. Based on a previously proposed and validated model, the current goal is to understand the role of various controllable parameters in the spray-freezing process. More specifically, given a set of spraying conditions, the model is used to predict the minimum distance required to cool and freeze the droplets below a temperature that prevents coalescence and product agglomeration. A parametric study is carried out to map the operational limit conditions of the actual spray-freezing column apparatus under consideration. For the spray freeze-drying conditions of interest, model simulations indicate that convection contributes to at least 80% of the total droplet heat transfer and, consequently, that freezing column gas temperature and droplet diameter are the most important process parameters affecting the freezing distance.

Identifiants

pubmed: 30682340
pii: S0022-3549(19)30019-X
doi: 10.1016/j.xphs.2019.01.011
pii:
doi:

Substances chimiques

Powders 0

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2075-2085

Informations de copyright

Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Auteurs

Israel B Sebastião (IB)

Purdue University, School of Aeronautics and Astronautics, West Lafayette, Indiana 47907; Pfizer Inc., BioTherapeutics Pharmaceutical Sciences, Andover, Massachusetts 01810.

Bakul Bhatnagar (B)

Pfizer Inc., BioTherapeutics Pharmaceutical Sciences, Andover, Massachusetts 01810.

Serguei Tchessalov (S)

Pfizer Inc., BioTherapeutics Pharmaceutical Sciences, Andover, Massachusetts 01810.

Satoshi Ohtake (S)

Pfizer Inc., BioTherapeutics Pharmaceutical Sciences, Chesterfield, Missouri 63198.

Matthias Plitzko (M)

Meridion Technologies GmbH, Müllheim, Germany.

Bernhard Luy (B)

Meridion Technologies GmbH, Müllheim, Germany.

Alina Alexeenko (A)

Purdue University, School of Aeronautics and Astronautics, West Lafayette, Indiana 47907. Electronic address: alexeenk@purdue.edu.

Articles similaires

Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Silicon Dioxide Water Hot Temperature Compressive Strength X-Ray Diffraction
Calcium Carbonate Sand Powders Construction Materials Materials Testing

Classifications MeSH